Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Dysport

PharmaCompass

01

Brand Name : Dysport

Abobotulinumtoxin A

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Dysport

arrow
2024 ACI Convention
Not Confirmed

Abobotulinumtoxin A

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 427

2019 Revenue in Millions : 470

Growth (%) : -9

blank

02

Brand Name : Dysport

Abobotulinumtoxin A

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Dysport

arrow
2024 ACI Convention
Not Confirmed

Abobotulinumtoxin A

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 478

2020 Revenue in Millions : 427

Growth (%) : 23

blank

03

Brand Name : Dysport

Abobotulinumtoxin A

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Dysport

arrow
2024 ACI Convention
Not Confirmed

Abobotulinumtoxin A

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 637

2021 Revenue in Millions : 478

Growth (%) : 33

blank

04

Brand Name : Dysport

Abobotulinumtoxin A

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Dysport

arrow
2024 ACI Convention
Not Confirmed

Abobotulinumtoxin A

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 700

2022 Revenue in Millions : 637

Growth (%) : 9

blank

05

Brand Name : Dysport

Abobotulinumtoxin A

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Dysport

arrow
2024 ACI Convention
Not Confirmed

Abobotulinumtoxin A

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 423

2018 Revenue in Millions : 379

Growth (%) : 12

blank